Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 Aug 15;254(1):239–244. doi: 10.1042/bj2540239

The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.

J Y Jeremy 1, G J Kontoghiorghes 1, A V Hoffbrand 1, P Dandona 1
PMCID: PMC1135063  PMID: 3140797

Abstract

The iron chelators desferrioxamine (DFO), 1,2-dimethyl(L1)-, 1-ethyl-2-methyl(L1NEt)- and 1-propyl-2-methyl(L1NPr)-3-hydroxypyrid-4-ones inhibited rat aortic prostacyclin (PGI2) synthesis in vitro (rank order of potency: DFO greater than L1 greater than L1NEt greater than L1NPr) when stimulated with adrenaline, arachidonate and the Ca2+ ionophore A23187. The inhibitory action of the chelators was blocked by Fe3+ and Al3+ and reversed by washing and H2O2, but not by ascorbate. These data suggest that iron chelators inhibit prostanoid synthesis in intact tissue through the removal or binding of Fe3+ linked to cyclo-oxygenase. These iron chelators may be of therapeutic value in the treatment of inflammatory and other diseases via two mechanisms: (1) the inhibition of pro-inflammatory prostanoid synthesis and (2) the inhibition of toxic-free-radical generation by cyclo-oxygenase.

Full text

PDF
240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakhle Y. S. Synthesis and catabolism of cyclo-oxygenase products. Br Med Bull. 1983 Jul;39(3):214–218. doi: 10.1093/oxfordjournals.bmb.a071821. [DOI] [PubMed] [Google Scholar]
  2. Gutteridge J. M., Richmond R., Halliwell B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J. 1979 Nov 15;184(2):469–472. doi: 10.1042/bj1840469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Halliwell B., Gutteridge J. M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984 Apr 1;219(1):1–14. doi: 10.1042/bj2190001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1973 Mar;70(3):899–903. doi: 10.1073/pnas.70.3.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hoffbrand A. V., Ganeshaguru K., Hooton J. W., Tattersall M. H. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol. 1976 Aug;33(4):517–526. doi: 10.1111/j.1365-2141.1976.tb03570.x. [DOI] [PubMed] [Google Scholar]
  6. Irvine R. F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem J. 1982 Apr 15;204(1):3–16. doi: 10.1042/bj2040003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jeremy J. Y., Dandona P. Fluoride stimulates in vitro vascular prostacyclin synthesis: interrelationship of G proteins and protein kinase C. Eur J Pharmacol. 1988 Feb 9;146(2-3):279–284. doi: 10.1016/0014-2999(88)90303-2. [DOI] [PubMed] [Google Scholar]
  8. Jeremy J. Y., Dandona P. Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486. Endocrinology. 1986 Aug;119(2):661–665. doi: 10.1210/endo-119-2-661. [DOI] [PubMed] [Google Scholar]
  9. Jeremy J. Y., Dandona P. RU486 antagonizes the inhibitory action of progesterone on prostacyclin and thromboxane A2 synthesis in cultured rat myometrial explants. Endocrinology. 1986 Aug;119(2):655–660. doi: 10.1210/endo-119-2-655. [DOI] [PubMed] [Google Scholar]
  10. Jeremy J. Y., Dandona P. The role of the diacylglycerol-protein kinase C system in mediating adrenoceptor-prostacyclin synthesis coupling in the rat aorta. Eur J Pharmacol. 1987 Apr 29;136(3):311–316. doi: 10.1016/0014-2999(87)90303-7. [DOI] [PubMed] [Google Scholar]
  11. Jeremy J. Y., Mikhailidis D. P., Dandona P. Adrenergic modulation of vascular prostacyclin (PGI2) secretion. Eur J Pharmacol. 1985 Aug 7;114(1):33–40. doi: 10.1016/0014-2999(85)90517-5. [DOI] [PubMed] [Google Scholar]
  12. Jeremy J. Y., Mikhailidis D. P., Dandona P. Prostanoid synthesis by the rat urinary bladder: evidence for stimulation through muscarine receptor-linked calcium channels. Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):463–467. doi: 10.1007/BF00569387. [DOI] [PubMed] [Google Scholar]
  13. Jeremy J. Y., Mikhailidis D. P., Dandona P. The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):70–73. doi: 10.1007/BF00633200. [DOI] [PubMed] [Google Scholar]
  14. Jeremy J. Y., Mikhailidis D. P., Dandona P. Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis. Eur J Pharmacol. 1985 Jan 2;107(2):259–262. doi: 10.1016/0014-2999(85)90066-4. [DOI] [PubMed] [Google Scholar]
  15. Jeremy J. Y., Mikhailidis D. P., Dandona P. Vascular trauma and prostacyclin release. Microcirc Endothelium Lymphatics. 1984 Oct;1(5):629–644. [PubMed] [Google Scholar]
  16. Kontoghiorghes G. J., Aldouri M. A., Sheppard L., Hoffbrand A. V. 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet. 1987 Jun 6;1(8545):1294–1295. doi: 10.1016/s0140-6736(87)90545-9. [DOI] [PubMed] [Google Scholar]
  17. Kontoghiorghes G. J. Iron mobilization from ferritin using alpha-oxohydroxy heteroaromatic chelators. Biochem J. 1986 Jan 1;233(1):299–302. doi: 10.1042/bj2330299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kontoghiorghes G. J., Jackson M. J., Lunec J. In vitro screening of iron chelators using models of free radical damage. Free Radic Res Commun. 1986;2(1-2):115–124. doi: 10.3109/10715768609088062. [DOI] [PubMed] [Google Scholar]
  19. Kontoghiorghes G. J. New orally active iron chelators. Lancet. 1985 Apr 6;1(8432):817–817. doi: 10.1016/s0140-6736(85)91472-2. [DOI] [PubMed] [Google Scholar]
  20. Kontoghiorghes G. J. Orally active alpha-ketohydroxypyridine iron chelators: effects on iron and other metal mobilisations. Acta Haematol. 1987;78(2-3):212–216. doi: 10.1159/000205877. [DOI] [PubMed] [Google Scholar]
  21. Kontoghiorghes G. J. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice. Mol Pharmacol. 1986 Dec;30(6):670–673. [PubMed] [Google Scholar]
  22. Kontoghiorghes G. J., Sheppard L., Chambers S. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones. Arzneimittelforschung. 1987 Oct;37(10):1099–1102. [PubMed] [Google Scholar]
  23. Kulmacz R. J., Lands W. E. Prostaglandin H synthase. Stoichiometry of heme cofactor. J Biol Chem. 1984 May 25;259(10):6358–6363. [PubMed] [Google Scholar]
  24. Lands W. E. The biosynthesis and metabolism of prostaglandins. Annu Rev Physiol. 1979;41:633–652. doi: 10.1146/annurev.ph.41.030179.003221. [DOI] [PubMed] [Google Scholar]
  25. Lewis G. P. Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation. Br Med Bull. 1983 Jul;39(3):243–248. doi: 10.1093/oxfordjournals.bmb.a071827. [DOI] [PubMed] [Google Scholar]
  26. Mason R. P., Kalyanaraman B., Tainer B. E., Eling T. E. A carbon-centered free radical intermediate in the prostaglandin synthetase oxidation of arachidonic acid. Spin trapping and oxygen uptake studies. J Biol Chem. 1980 Jun 10;255(11):5019–5022. [PubMed] [Google Scholar]
  27. Muirden K. D. Ferritin in synovial cells in patients with rheumatoid arthritis. Ann Rheum Dis. 1966 Sep;25(5):387–401. doi: 10.1136/ard.25.5.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nugteren D. H., Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973 Dec 20;326(3):448–461. doi: 10.1016/0005-2760(73)90145-8. [DOI] [PubMed] [Google Scholar]
  29. Polgar P., Taylor L. Stimulation of prostaglandin synthesis by ascorbic acid via hydrogen peroxide formation. Prostaglandins. 1980 May;19(5):693–700. doi: 10.1016/0090-6980(80)90168-9. [DOI] [PubMed] [Google Scholar]
  30. SAMUELSSON B. ON THE INCORPORATION OF OXYGEN IN THE CONVERSION OF 8, 11, 14-EICOSATRIENOIC ACID TO PROSTAGLANDIN E1. J Am Chem Soc. 1965 Jul 5;87:3011–3013. doi: 10.1021/ja01091a043. [DOI] [PubMed] [Google Scholar]
  31. Slater T. F. Free-radical mechanisms in tissue injury. Biochem J. 1984 Aug 15;222(1):1–15. doi: 10.1042/bj2220001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Warso M. A., Lands W. E. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull. 1983 Jul;39(3):277–280. doi: 10.1093/oxfordjournals.bmb.a071833. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES